Abstract
Muscle-invasive urothelial carcinoma (MIUC) is the most common type of bladder malignancy in humans, but also in dogs that represent a naturally occurring model for this disease. Dogs are immunocompetent animals that share risk factors, pathophysiological features, clinical signs and response to chemotherapeutics with human cancer patients. This review summarizes the fundamental pathways for canine MIUC initiation, progression, and metastasis, emerging therapeutic targets and mechanisms of drug resistance, and proposes new opportunities for potential prognostic and diagnostic biomarkers and therapeutics. Identifying similarities and differences between cancer signaling in dogs and humans is of utmost importance for the efficient translation of in vitro research to successful clinical trials for both species.
Funder
Maxine Adler Fellowship Award, UC Davis School of Veterinary Medicine
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference177 articles.
1. Key Statistics for Bladder Cancerhttps://www.cancer.org/cancer/bladder-cancer/about/key-statistics.html
2. Survival Rates for Bladder Cancerhttps://www.cancer.org/cancer/bladder-cancer/detection-diagnosis-staging/survival-rates.html
3. Treatment of Bladder Cancer, by Stagehttps://www.cancer.org/cancer/bladder-cancer/treating/by-stage.html
4. Cisplatin and gemcitabine versus carboplatin and gemcitabine in metastatic bladder cancer: Survival analysis of veterans' health care data.
5. Immunotherapy for Bladder Cancerhttps://www.cancer.org/cancer/bladder-cancer/treating/immunotherapy-for-bladder-cancer.html
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献